Philanthropy
1 minute read
An initial public offering (IPO) can create a step change in both wealth and financial complexity. Equity in the company now looks like liquidity, but it also represents a new kind of portfolio concentration: a larger share of net worth tied to a single public stock, new tax and trading constraints, and a heightened need for a disciplined plan that can hold up through market cycles.
A resilient post‑IPO approach starts by clarifying your long-term goals, and then building a portfolio designed to maximize the probability of achieving those goals, all while staying invested through different market environments.
After an IPO, diversification is rarely a binary choice to sell or hold. Instead, it tends to be a decision about role: What role should the company stock play in your financial life going forward?
While generic rules often advise a fixed maximum percentage in a single stock, those guidelines may not be all that relevant immediately after an IPO. For many post‑IPO founders, executives and employees, concentration may be unavoidable for some time. Depending on your view of the company’s prospects, it may even be desirable. Instead, focus on your acceptable level of concentration—based on your circumstances, objectives and tolerance for risk.
It can be helpful to define a minimum dose of diversification. That’s the minimum amount you need to diversify (net of expected taxes and costs) to keep goals funded under a range of market outcomes.
Once you’ve decided on an appropriate level of diversification, set explicit targets:
Why sequencing matters
Not all shares are the same. Post‑IPO exposure may be held across RSUs, NQSOs, ISOs and long-held common shares—each with different tax implications and planning constraints. Understanding what you own and identifying what to sell, and when, can reduce friction and maximize your choices without unintentionally increasing risk elsewhere.
A typical sequence
To optimize your after-tax proceeds, start by selling your highest basis shares first, being mindful to not sell out of QSBS-eligible or ISO shares before they’ve hit their holding periods. For many, this can include selling RSUs as they vest. Vesting typically triggers taxation, and the RSUs can provide a consistent source of liquidity and diversification. Keep in mind that long shares are the only type of equity that can be used as collateral for a loan or a gift to charity.
Stress test against likely scenarios
Next, consider how’ll your adapt your plan as your equity gains or loses value.
The answers to these questions will help inform your sales plan and the appropriate limit prices and approach for various market scenarios.
If applicable, consider a 10b5‑1 plan
Insiders have an additional consideration as they look to diversify their holdings: how their stock sales will be perceived by the market. Often, it makes sense to sell via a 10b5-1 plan. A 10b5-1 plan helps implement systematic sales in a compliant, disciplined way over time, removing the uncertainty of ad hoc decisions and the market reaction that may accompany them.
A 10b5-1 allows insiders to enter into a sales plan during an open window when they aren’t in possession of material non-public information. Trades take place at a later date in line with pre-established limit prices, relieving insiders of having to actively choose a precise time to sell.
An IPO can shift both your balance sheet and your psychology. A disciplined portfolio construction philosophy can help prevent drift as markets move, restrictions change and priorities evolve.
Goal alignment comes first
Your portfolio should be built to maximize the probability of achieving your goals, incorporating inflation and your preferences to keep you invested through market cycles. Post‑IPO, this often starts with a wealth plan that segments assets by intent—funding near‑term liquidity needs, medium‑term objectives and long‑term growth—so you are not forced to sell growth assets at the wrong time.
Establish a strategic foundation, then make decisions
A strong approach typically anchors portfolios in an efficient strategic asset allocation informed by long-term assumptions. It then expresses high-conviction views selectively and at appropriate size.
After an IPO, a high concentration of company stock is generally already a large exposure; the rest of the portfolio often works best when it restores balance rather than layering on additional unintended risk.
Diversification should be designed, not accidental
Assets respond differently across market environments, and resilient portfolios aim to grow and protect across a range of outcomes. Post‑IPO, that typically means treating the retained company stock as an explicit allocation and building the remainder of the portfolio to offset concentration.
Risk-taking is intentional
Every position should earn its place in a portfolio with its effect on portfolio risk and the opportunity cost of holding it. Risk should be used intentionally: It’s either minimized to achieve goals or used to seek higher long-term returns within clear guardrails. This lens can be especially helpful if you notice yourself holding a concentrated stock simply because you’re waiting for a price target or a “better moment.” A practical reframe—such as, “if you didn’t own it today, would you buy it at this size?”—can help reconnect decisions to goals.
Fees and taxes are part of outcomes
Investment decisions are best evaluated on an after-fee, after-tax basis, using implementation and asset location choices to improve net results. This often shows up in sales plan design, tax-aware rebalancing, charitable planning where appropriate, and ongoing scrutiny of fees.
Reassess regularly
Risk and return should be measured over time across multiple dimensions, and portfolios should be reassessed systematically as markets and circumstances evolve. After an IPO, this is especially important as lock-ups expire, trading windows open and close, and personal priorities shift from accumulation toward preservation.
Here are six steps to building a strong post-IPO plan:
After an IPO, a concentrated position in your company’s stock presents both an opportunity and a risk. Only by sizing that concentration—alongside trading constraints, tax considerations and the proceeds needed by you and your family—can you begin to choose from the many solutions that may be available.
Speak to your J.P. Morgan team about assessing your post‑IPO concentration. Together, you can address concerns about market volatility or stock-specific risk and build a durable plan—one that supports disciplined diversification, thoughtful portfolio construction and your long-term financial goals.
We can help you navigate a complex financial landscape. Reach out today to learn how.
Contact usLEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck
To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products.
JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.
Please read the Legal Disclaimer for J.P. Morgan Private Bank regional affiliates and other important information in conjunction with these pages.
Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC.
Not a commitment to lend. All extensions of credit are subject to credit approval.